- Liver Disease and Transplantation
- Liver Disease Diagnosis and Treatment
- Ferroptosis and cancer prognosis
- Curcumin's Biomedical Applications
- Chemical Reactions and Isotopes
- Adipose Tissue and Metabolism
- Cancer Mechanisms and Therapy
- Cancer-related molecular mechanisms research
- Cancer-related Molecular Pathways
- Biochemical effects in animals
- FOXO transcription factor regulation
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- RNA modifications and cancer
- Inflammatory mediators and NSAID effects
- Venous Thromboembolism Diagnosis and Management
- Biomarkers in Disease Mechanisms
- Hepatocellular Carcinoma Treatment and Prognosis
- Adenosine and Purinergic Signaling
- MicroRNA in disease regulation
- Circular RNAs in diseases
- Synthesis and biological activity
- Nanoplatforms for cancer theranostics
Sun Yat-sen University
2024-2025
Xihua University
2024
Ningbo University
2024
Zhongnan Hospital of Wuhan University
2022-2024
Wuhan University
2022-2024
Hubei Provincial Center for Disease Control and Prevention
2024
Purpose: Lung adenocarcinoma (LUAD) is a prevalent malignant tumor worldwide, with high incidence and mortality rates. However, there still lack of specific sensitive biomarkers for its early diagnosis targeted treatment. Disulfidptosis newly identified mode cell death that characteristic disulfide stress. Therefore, exploring the correlation between disulfidptosis-related long non-coding RNAs (DRGs-lncRNAs) patient prognosis can provide new molecular targets LUAD patients. Methods: The...
It has been increasingly recognized that circular RNAs (circRNAs) act as a pivotal factor in the onset and progression of human malignancies. Yet, specific activities mechanistic roles these context lung adenocarcinoma (LUAD) are not fully understood.
Lung adenocarcinoma (LUAD) is the most common lung cancer subtype, and prognosis of affected patients generally poor. The traditional Chinese medicine Uncaria rhychophaylla has been reported to exhibit anti-lung properties. Accordingly, main bioactive ingredient in rhychophaylla, Corynoxine, may hold great value as a treatment for cancer.